XBiotech Inc. — Director's Dealing 2019

Dec 11, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: XBiotech Inc. (XBIT)
CIK: 0001626878
Period of Report: 2019-12-06

Reporting Person: SIMARD JOHN (Director, Chief Executive Officer, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-12-06	Stock Option	$11.12	M	1000000	Acquired	2029-12-11	Common Stock (1000000)	Direct

Footnotes

F1: On December 6, 2019 (the Grant Date) John Simard was granted nonstatutory stock options under the Company's 2015 Equity Incentive Plan to purchase shares of the Company's Common Stock at an exercise price equal to the closing price of the Company's common stock, as reported by the Nasdaq Stock Market, on the Grant Date. The options will vest in two equal installments on the six-month anniversary and the first anniversary of the Grant Date.